
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in mice
Nicolas Arbez, XiaoFei He, Yong Huang, et al.
Human Molecular Genetics (2019) Vol. 29, Iss. 4, pp. 580-590
Open Access | Times Cited: 37
Nicolas Arbez, XiaoFei He, Yong Huang, et al.
Human Molecular Genetics (2019) Vol. 29, Iss. 4, pp. 580-590
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
E. Maruthi Prasad, Shih‐Ya Hung
Antioxidants (2020) Vol. 9, Iss. 10, pp. 1007-1007
Open Access | Times Cited: 90
E. Maruthi Prasad, Shih‐Ya Hung
Antioxidants (2020) Vol. 9, Iss. 10, pp. 1007-1007
Open Access | Times Cited: 90
Chemically induced models of Parkinson's disease
Thilaga Thirugnanam, Kirankumar Santhakumar
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2021) Vol. 252, pp. 109213-109213
Closed Access | Times Cited: 48
Thilaga Thirugnanam, Kirankumar Santhakumar
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2021) Vol. 252, pp. 109213-109213
Closed Access | Times Cited: 48
The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play
Sonia Azeggagh, Daniel C. Berwick
British Journal of Pharmacology (2021) Vol. 179, Iss. 8, pp. 1478-1495
Open Access | Times Cited: 47
Sonia Azeggagh, Daniel C. Berwick
British Journal of Pharmacology (2021) Vol. 179, Iss. 8, pp. 1478-1495
Open Access | Times Cited: 47
Progress in LRRK2-Associated Parkinson’s Disease Animal Models
Steven P. Seegobin, George R. Heaton, Dongxiao Liang, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 41
Steven P. Seegobin, George R. Heaton, Dongxiao Liang, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 41
Astrocytes in Neurodegeneration: Inspiration From Genetics
Jingxuan Huang, Chunyu Li, Huifang Shang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 24
Jingxuan Huang, Chunyu Li, Huifang Shang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 24
The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson’s Disease
Xu Tang, Shuaishuai Xing, Mingkang Ma, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2282-2307
Closed Access | Times Cited: 14
Xu Tang, Shuaishuai Xing, Mingkang Ma, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2282-2307
Closed Access | Times Cited: 14
LRRK2 at the Crossroad of Aging and Parkinson’s Disease
Eun‐Mi Hur, Byoung Dae Lee
Genes (2021) Vol. 12, Iss. 4, pp. 505-505
Open Access | Times Cited: 28
Eun‐Mi Hur, Byoung Dae Lee
Genes (2021) Vol. 12, Iss. 4, pp. 505-505
Open Access | Times Cited: 28
Oxidative phosphorylation mediated pathogenesis of Parkinson's disease and its implication via Akt signaling
MD. Zainul Ali, Pankaj Singh Dholaniya
Neurochemistry International (2022) Vol. 157, pp. 105344-105344
Closed Access | Times Cited: 18
MD. Zainul Ali, Pankaj Singh Dholaniya
Neurochemistry International (2022) Vol. 157, pp. 105344-105344
Closed Access | Times Cited: 18
LRRK2: Genetic mechanisms vs genetic subtypes
Ignácio F. Mata, Philippe A. Salles, Mario Cornejo‐Olivas, et al.
Handbook of clinical neurology (2023), pp. 133-154
Closed Access | Times Cited: 10
Ignácio F. Mata, Philippe A. Salles, Mario Cornejo‐Olivas, et al.
Handbook of clinical neurology (2023), pp. 133-154
Closed Access | Times Cited: 10
Parkinson's disease and glucose metabolism impairment
Liangjing Chen, Chunyu Wang, Lixia Qin, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
Liangjing Chen, Chunyu Wang, Lixia Qin, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons
Hoang Kieu Chi Ngo, Akriti Srivastava, Hoang Le, et al.
BMC Neuroscience (2025) Vol. 26, Iss. 1
Open Access
Hoang Kieu Chi Ngo, Akriti Srivastava, Hoang Le, et al.
BMC Neuroscience (2025) Vol. 26, Iss. 1
Open Access
The nuclear export signal mediates mutant atrophin-1-induced neuropathology in a mouse model of DRPLA
Yideng Liang, Bo Ning, Xiaobo Wang, et al.
Human Molecular Genetics (2025)
Closed Access
Yideng Liang, Bo Ning, Xiaobo Wang, et al.
Human Molecular Genetics (2025)
Closed Access
Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism
Vinita G. Chittoor-Vinod, R. Jeremy Nichols, Birgitt Schüle
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1045-1045
Open Access | Times Cited: 23
Vinita G. Chittoor-Vinod, R. Jeremy Nichols, Birgitt Schüle
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1045-1045
Open Access | Times Cited: 23
Pathogenic Aspects and Therapeutic Avenues of Autophagy in Parkinson’s Disease
Rémi Kinet, Benjamin Dehay
Cells (2023) Vol. 12, Iss. 4, pp. 621-621
Open Access | Times Cited: 9
Rémi Kinet, Benjamin Dehay
Cells (2023) Vol. 12, Iss. 4, pp. 621-621
Open Access | Times Cited: 9
Microglial Sp1 induced LRRK2 upregulation in response to manganese exposure, and 17β-estradiol afforded protection against this manganese toxicity
Ivan Nyarko‐Danquah, Edward Pajarillo, Sang Hoon Kim, et al.
NeuroToxicology (2024) Vol. 103, pp. 105-114
Closed Access | Times Cited: 2
Ivan Nyarko‐Danquah, Edward Pajarillo, Sang Hoon Kim, et al.
NeuroToxicology (2024) Vol. 103, pp. 105-114
Closed Access | Times Cited: 2
Neuroimmune multi-hit perspective of coronaviral infection
Shawn Hayley, Hongyu Sun
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Shawn Hayley, Hongyu Sun
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 16
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity
Salvatore Novello, Daniela Mercatelli, Federica Albanese, et al.
Neurobiology of Disease (2021) Vol. 162, pp. 105579-105579
Open Access | Times Cited: 16
Salvatore Novello, Daniela Mercatelli, Federica Albanese, et al.
Neurobiology of Disease (2021) Vol. 162, pp. 105579-105579
Open Access | Times Cited: 16
Curcumin Reduced H2O2- and G2385R-LRRK2-Induced Neurodegeneration
Jinru Zhang, Kai Li, Xiaobo Wang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 13
Jinru Zhang, Kai Li, Xiaobo Wang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 13
Modeling Parkinson’s disease in LRRK2 rodents
Chiara Domenicale, Stefano Magnabosco, Michele Morari
Neuronal Signaling (2023) Vol. 7, Iss. 3
Open Access | Times Cited: 5
Chiara Domenicale, Stefano Magnabosco, Michele Morari
Neuronal Signaling (2023) Vol. 7, Iss. 3
Open Access | Times Cited: 5
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice
Chiara Domenicale, Daniela Mercatelli, Federica Albanese, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 881-881
Open Access | Times Cited: 8
Chiara Domenicale, Daniela Mercatelli, Federica Albanese, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 881-881
Open Access | Times Cited: 8
Impaired SHH responsiveness of induced pluripotent stem cell-derived floor plate cells carrying the LRRK2 I1371V mutation contributes to the ontogenic origin of lower dopaminergic-neuron yield
Chandrakanta Potdar, Soham Jagtap, Khushboo Singh, et al.
Stem Cells and Development (2024) Vol. 33, Iss. 11-12, pp. 306-320
Closed Access | Times Cited: 1
Chandrakanta Potdar, Soham Jagtap, Khushboo Singh, et al.
Stem Cells and Development (2024) Vol. 33, Iss. 11-12, pp. 306-320
Closed Access | Times Cited: 1
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology
Fatema Currim, Reeya Tanwar, Josephine M. Brown-Leung, et al.
NeuroToxicology (2024) Vol. 103, pp. 266-287
Closed Access | Times Cited: 1
Fatema Currim, Reeya Tanwar, Josephine M. Brown-Leung, et al.
NeuroToxicology (2024) Vol. 103, pp. 266-287
Closed Access | Times Cited: 1
Microbiome-based therapies for Parkinson’s disease
Mudassir Alam, Kashif Abbas, Mohd Rais Mustafa, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
Mudassir Alam, Kashif Abbas, Mohd Rais Mustafa, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
Mutant-TMEM230-induced neurodegeneration and impaired axonal mitochondrial transport
Xiaobo Wang, Gongbo Guo, Jinru Zhang, et al.
Human Molecular Genetics (2021) Vol. 30, Iss. 16, pp. 1535-1542
Closed Access | Times Cited: 9
Xiaobo Wang, Gongbo Guo, Jinru Zhang, et al.
Human Molecular Genetics (2021) Vol. 30, Iss. 16, pp. 1535-1542
Closed Access | Times Cited: 9
Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years
Alice Filippini, Massimo Gennarelli, Isabella Russo
Biochemical Society Transactions (2021) Vol. 49, Iss. 3, pp. 1375-1384
Closed Access | Times Cited: 8
Alice Filippini, Massimo Gennarelli, Isabella Russo
Biochemical Society Transactions (2021) Vol. 49, Iss. 3, pp. 1375-1384
Closed Access | Times Cited: 8